224 related articles for article (PubMed ID: 18720522)
1. Telomere-mediated genomic instability and the clinico-pathological parameters in breast cancer.
Poonepalli A; Banerjee B; Ramnarayanan K; Palanisamy N; Putti TC; Hande MP
Genes Chromosomes Cancer; 2008 Dec; 47(12):1098-109. PubMed ID: 18720522
[TBL] [Abstract][Full Text] [Related]
2. Expression of telomere-associated genes as prognostic markers for overall survival in patients with non-small cell lung cancer.
Lin X; Gu J; Lu C; Spitz MR; Wu X
Clin Cancer Res; 2006 Oct; 12(19):5720-5. PubMed ID: 17020976
[TBL] [Abstract][Full Text] [Related]
3. Tankyrase 1 as a target for telomere-directed molecular cancer therapeutics.
Seimiya H; Muramatsu Y; Ohishi T; Tsuruo T
Cancer Cell; 2005 Jan; 7(1):25-37. PubMed ID: 15652747
[TBL] [Abstract][Full Text] [Related]
4. Expression of telomeric repeat binding factor 1 and 2 and TRF1-interacting nuclear protein 2 in human gastric carcinomas.
Matsutani N; Yokozaki H; Tahara E; Tahara H; Kuniyasu H; Haruma K; Chayama K; Yasui W; Tahara E
Int J Oncol; 2001 Sep; 19(3):507-12. PubMed ID: 11494028
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of TRF1, TRF2 and TIN2 genes is important to maintain telomeric DNA for gastric cancers.
Yamada M; Tsuji N; Nakamura M; Moriai R; Kobayashi D; Yagihashi A; Watanabe N
Anticancer Res; 2002; 22(6A):3303-7. PubMed ID: 12530079
[TBL] [Abstract][Full Text] [Related]
6. Telomere elongation by a mutant tankyrase 1 without TRF1 poly(ADP-ribosyl)ation.
Muramatsu Y; Tahara H; Ono T; Tsuruo T; Seimiya H
Exp Cell Res; 2008 Mar; 314(5):1115-24. PubMed ID: 18221737
[TBL] [Abstract][Full Text] [Related]
7. Expression of telomere binding proteins in gastric cancer and correlation with clinicopathological parameters.
Gao J; Zhang J; Long Y; Lu X
Asia Pac J Clin Oncol; 2011 Dec; 7(4):339-45. PubMed ID: 22151982
[TBL] [Abstract][Full Text] [Related]
8. Tankyrase, a positive regulator of telomere elongation, is over expressed in human breast cancer.
Gelmini S; Poggesi M; Distante V; Bianchi S; Simi L; Luconi M; Raggi CC; Cataliotti L; Pazzagli M; Orlando C
Cancer Lett; 2004 Dec; 216(1):81-7. PubMed ID: 15500951
[TBL] [Abstract][Full Text] [Related]
9. Correlations of telomere length, telomerase activity, and telomeric-repeat binding factor 1 expression in colorectal carcinoma.
Garcia-Aranda C; de Juan C; Diaz-Lopez A; Sanchez-Pernaute A; Torres AJ; Diaz-Rubio E; Balibrea JL; Benito M; Iniesta P
Cancer; 2006 Feb; 106(3):541-51. PubMed ID: 16388518
[TBL] [Abstract][Full Text] [Related]
10. TIN2 is a tankyrase 1 PARP modulator in the TRF1 telomere length control complex.
Ye JZ; de Lange T
Nat Genet; 2004 Jun; 36(6):618-23. PubMed ID: 15133513
[TBL] [Abstract][Full Text] [Related]
11. Quantitative and spatial measurements of telomerase reverse transcriptase expression within normal and malignant human breast tissues.
Hines WC; Fajardo AM; Joste NE; Bisoffi M; Griffith JK
Mol Cancer Res; 2005 Sep; 3(9):503-9. PubMed ID: 16179497
[TBL] [Abstract][Full Text] [Related]
12. Telomerase activity in B-cell non-Hodgkin lymphomas is regulated by hTERT transcription and correlated with telomere-binding protein expression but uncoupled from proliferation.
Klapper W; Krams M; Qian W; Janssen D; Parwaresch R
Br J Cancer; 2003 Aug; 89(4):713-9. PubMed ID: 12915884
[TBL] [Abstract][Full Text] [Related]
13. Telomere instability and cancer.
Londoño-Vallejo JA
Biochimie; 2008 Jan; 90(1):73-82. PubMed ID: 17728038
[TBL] [Abstract][Full Text] [Related]
14. Coordinate regulation between expression levels of telomere-binding proteins and telomere length in breast carcinomas.
Butler KS; Hines WC; Heaphy CM; Griffith JK
Cancer Med; 2012 Oct; 1(2):165-75. PubMed ID: 23342266
[TBL] [Abstract][Full Text] [Related]
15. Cross-species difference in telomeric function of tankyrase 1.
Muramatsu Y; Ohishi T; Sakamoto M; Tsuruo T; Seimiya H
Cancer Sci; 2007 Jun; 98(6):850-7. PubMed ID: 17433040
[TBL] [Abstract][Full Text] [Related]
16. Telomere length and regulatory proteins in human skeletal muscle with and without ongoing regenerative cycles.
Ponsot E; Echaniz-Laguna A; Delis AM; Kadi F
Exp Physiol; 2012 Jun; 97(6):774-84. PubMed ID: 22366562
[TBL] [Abstract][Full Text] [Related]
17. Modulation of telomere shelterin by TRF1 [corrected] and TRF2 interacts with telomerase to maintain the telomere length in non-small cell lung cancer.
Hsu CP; Ko JL; Shai SE; Lee LW
Lung Cancer; 2007 Dec; 58(3):310-6. PubMed ID: 17681636
[TBL] [Abstract][Full Text] [Related]
18. Telomeric associations correlate with telomere length reduction and clonal chromosome aberrations in giant cell tumor of bone.
Gebre-Medhin S; Broberg K; Jonson T; Gorunova L; von Steyern FV; Brosjö O; Jin Y; Gisselsson D; Panagopoulos I; Mandahl N; Mertens F
Cytogenet Genome Res; 2009; 124(2):121-7. PubMed ID: 19420923
[TBL] [Abstract][Full Text] [Related]
19. Analysis of telomerase activity levels in breast cancer: positive detection at the in situ breast carcinoma stage.
Bednarek AK; Sahin A; Brenner AJ; Johnston DA; Aldaz CM
Clin Cancer Res; 1997 Jan; 3(1):11-6. PubMed ID: 9815531
[TBL] [Abstract][Full Text] [Related]
20. Radiation and chemotherapy bystander effects induce early genomic instability events: telomere shortening and bridge formation coupled with mitochondrial dysfunction.
Gorman S; Tosetto M; Lyng F; Howe O; Sheahan K; O'Donoghue D; Hyland J; Mulcahy H; O'Sullivan J
Mutat Res; 2009 Oct; 669(1-2):131-8. PubMed ID: 19540247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
